AllianceBernstein
PYXS icon

AllianceBernstein’s Pyxis Oncology PYXS Stock Holding History

AllianceBernstein’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,470
Closed -$13.2K – 3309
2025
Q1 		$13.2K Hold
13,470
– – ﹤0.01% 3187
2024
Q4 		$21K Hold
13,470
– – ﹤0.01% 3210
2024
Q3 		$49.4K Hold
13,470
– – ﹤0.01% 3191
2024
Q2 		$44.6K Buy
+13,470
New +$56.6K ﹤0.01% 3199

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's PYXS Position: Q2 2025 in Review

AllianceBernstein sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 13,470 shares — an estimated $13.2K sold.

AllianceBernstein first reported a position in PYXS in Q2 2024 and held it in 4 quarters. The position peaked at $49.4K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • AllianceBernstein reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 13,470 Pyxis Oncology shares in Q2 2025, an estimated $13.2K.
  • AllianceBernstein first reported a position in Pyxis Oncology in Q2 2024 and held it in 4 quarters.
  • AllianceBernstein's Pyxis Oncology position peaked at $49.4K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.